Human TROP-2 Antibody Summary
Thr88-Thr274
Accession # P09758
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human TROP‑2 by Western Blot. Western blot shows lysates of NCI-N87 human gastric carcinoma cell line. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human TROP-2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF650) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for TROP-2 at approximately 45-50 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 8.
Detection of TROP‑2 in PC‑3 Human Cell Line by Flow Cytometry. PC-3 human prostate cancer cell line was stained with Goat Anti-Human TROP-2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF650, filled histogram) or control antibody (Catalog # AB-108-C, open histogram), followed by Phycoerythrin-conjugated Anti-Goat IgG Secondary Antibody (Catalog # F0107).
TROP‑2 in Human Brain. TROP-2 was detected in immersion fixed paraffin-embedded sections of human brain (frontal cortex) using Goat Anti-Human TROP-2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF650) at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TROP-2
Human TROP-2, also called tumor associated calcium signal transducer 2 (TACSTD2), GA733-1, gp50 and T16, is a type I cell surface glycoprotein that is highly expressed on human carcinomas. It was originally identified as an antigen present on human gastrointestinal tumors and is the second of two members of this family. The other family member is GA733-2, also called EpCAM, TROP-1, 17-1A, gp40 and KSA. The TROP-2 gene is unique in that it contains no introns. A study of these two genes suggested that TROP-2 was the result of a retroposition of the EpCAM gene. TROP-2 and EpCAM share approximately 49% amino acid identity and approximately 67% similarity. Human and mouse TROP-2 share 87% similarity. The human TROP-2 protein consists of a putative 26 amino acid (aa) signal sequence, a 248 aa extracellular domain, a 23 aa transmembrane region and a 26 aa cytoplasmic domain. TROP-2 is capable of transducing an intracellular calcium signal and may play a role in tumor growth. It also has adhesive functions.
- Linnenbach, A.J. et al. (1989) Proc. Natl. Acad. Sci. USA 86:27.
- Linnenbach, A.J. et al. (1993) Mol. Cell. Biol. 13:1507.
- Fornaro, M. et al. (1995) Int. J. Cancer 62:610.
- Ripani, E. et al. (1998) Int. J. Cancer 76:671.
- El Sewedy, T. et al. (1998) Int. J. Cancer 75:324.
Product Datasheets
Citations for Human TROP-2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
20
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Rescue of secretion of a rare-disease associated mis-folded mutant glycoprotein in UGGT1 knock-out mammalian cells
Authors: Tax, G;Guay, KP;Soldà, T;Hitchman, CJ;Hill, JC;Vasiljevi?, S;Lia, A;Modenutti, CP;Straatman, KR;Santino, A;Molinari, M;Zitzmann, N;Hebert, DN;Roversi, P;Trerotola, M;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae
Authors: JY Seok, X Fan
Annals of diagnostic pathology, 2022-01-31;57(0):151903.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release
Authors: PR Kamble, SR Patkar, AA Breed, BR Pathak
Archives of biochemistry and biophysics, 2021-11-10;714(0):109084.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: ICC, Western Blot -
miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development
Authors: Y Hao, D Zhang, Y Guo, Z Fu, D Yu, G Guan
J Cancer, 2020-03-05;11(11):3375-3386.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
Authors: B Zeybek, A Manzano, A Bianchi, E Bonazzoli, S Bellone, N Buza, P Hui, S Lopez, E Perrone, P Manara, L Zammataro, G Altwerger, C Han, J Tymon-Rosa, G Menderes, E Ratner, DA Silasi, GS Huang, M Azodi, PE Schwartz, A Santin
Sci Rep, 2020-01-22;10(1):973.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells
Authors: X Kuai, L Jia, T Yang, X Huang, W Zhao, M Zhang, Y Chen, J Zhu, Z Feng, Q Tang
Med. Sci. Monit., 2020-01-22;26(0):e919566.
Species: Human
Sample Types: Cell Lysate
Applications: Western Blot -
In�vitro and in�vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma
Authors: C Han, E Perrone, B Zeybek, S Bellone, J Tymon-Rosa, G Altwerger, G Menderes, J Feinberg, K Haines, ME Muller Kar, A Bianchi, L Zammataro, A Manzano, E Bonazzoli, P Manara, N Buza, P Hui, E Ratner, DA Silasi, GS Huang, M Azodi, PE Schwartz, S Lopez, AD Santin
Gynecol. Oncol., 2019-12-12;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling
Authors: STK Sin, Y Li, M Liu, S Ma, XY Guan
Gynecol. Oncol., 2018-11-12;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast
Authors: S Vranic, J Palazzo, S Sanati, E Florento, E Contreras, J Xiu, J Swensen, Z Gatalica
Clin. Breast Cancer, 2018-09-05;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Authors: SM Zimmers, EP Browne, KE Williams, RM Jawale, CN Otis, SS Schneider, KF Arcaro
Cancer Cell Int., 2018-07-06;18(0):94.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma
Authors: N Redlich, AM Robinson, KP Nickel, AP Stein, DL Wheeler, DR Adkins, R Uppaluri, RJ Kimple, BA Van Tine, LS Michel
Cell Death Dis, 2018-01-05;9(1):5.
Species: Xenograft
Sample Types: Tissue Homogenates, Whole Tissue
Applications: IHC, Western Blot -
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
Authors: H Guan, Z Guo, W Liang, H Li, G Wei, L Xu, H Xiao, Y Li
BMC Cancer, 2017-07-14;17(1):486.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.
Authors: Starodub A, Ocean A, Shah M, Guarino M, Picozzi V, Vahdat L, Thomas S, Govindan S, Maliakal P, Wegener W, Hamburger S, Sharkey R, Goldenberg D
Clin Cancer Res, 2015-05-05;21(17):3870-8.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis.
Authors: Xia Y, Li B, Gao N, Xia H, Men Y, Liu Y, Liu Z, Chen Q, Li L
Oncol Lett, 2014-07-31;8(4):1670-1674.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Trop-2 is a determinant of breast cancer survival.
Authors: Ambrogi, Federico, Fornili, Marco, Boracchi, Patrizia, Trerotola, Marco, Relli, Valeria, Simeone, Pasquale, La Sorda, Rossana, Lattanzio, Rossano, Querzoli, Patrizia, Pedriali, Massimo, Piantelli, Mauro, Biganzoli, Elia, Alberti, Saverio
PLoS ONE, 2014-05-13;9(5):e96993.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: Flow Cytometry, IHC-P -
Upregulation of Trop-2 quantitatively stimulates human cancer growth.
Authors: Trerotola, M, Cantanelli, P, Guerra, E, Tripaldi, R, Aloisi, A L, Bonasera, V, Lattanzio, R, de Lange, R, Weidle, U H, Piantelli, M, Alberti, S
Oncogene, 2012-02-20;32(2):222-33.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
Authors: Raji R, Guzzo F, Carrara L
J. Exp. Clin. Cancer Res., 2011-11-10;30(0):106.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-beta1-dependent human epidermal Langerhans cells.
Authors: Eisenwort G, Jurkin J, Yasmin N, Bauer T, Gesslbauer B, Strobl H
J. Invest. Dermatol., 2011-06-16;131(10):2049-57.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: Flow Cytometry, ICC, IHC-Fr -
Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy.
Authors: Nakatsukasa M, Kawasaki S, Yamasaki K
Am. J. Pathol., 2010-07-22;177(3):1344-55.
Species: Human
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC-P, Immunoprecipitation -
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers.
Authors: Wang J, Day R, Dong Y, Weintraub SJ, Michel L
Mol. Cancer Ther., 2008-02-01;7(2):280-5.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human TROP-2 Antibody
There are currently no reviews for this product. Be the first to review Human TROP-2 Antibody and earn rewards!
Have you used Human TROP-2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image